Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,187 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,187 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,187 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,187 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,187 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,187 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,187 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
17 Feb 2026
Ramiro Ribeiro Chief Medical Officer
Sold on a plan
$36.56K 2,437 at 15.00
100%
Sold half or more
17 Feb 2026
Theresa A Shaw SVP and CATO
Sold on a plan
$36.36K 325 at 111.89
0.9%
Planned (10b5-1)
17 Feb 2026
Richard A. Heyman Director · indirect
Sold on a plan
$32.20K 1,230 at 26.18
5.2%
Planned (10b5-1)
17 Feb 2026
Timothy Edward Lee Chief Commercial Officer also filed by William E. Duke, Julie Green
Sold on a plan
$30.27K 19,663 at 1.54
12.4%
Planned (10b5-1)
17 Feb 2026
Steven Yi See Remarks
Sold on a plan
$28.64K 4,000 at 7.16
0.1%
Planned (10b5-1)
17 Feb 2026
Robert D. Allen III Chief Scientific Officer
Sold on a plan
$28.00K 18,189 at 1.54
12.0%
Planned (10b5-1)
17 Feb 2026
Josef Parvizi Director · indirect
Sold on a plan
$26.00K 1,300 at 20.00
0.2%
Planned (10b5-1)
17 Feb 2026
Lorenzo Daniel De VP, Controller & CAO
Sold on a plan
$25.66K 252 at 101.84
100%
Sold half or more
17 Feb 2026
Michael Wayne Domino Jr. President, DTR Division
Sold on a plan 2×
$24.75K 6,249 at 3.96
0.4%
Planned (10b5-1)
17 Feb 2026
Jan Malcolm Director
Sold on a plan
$23.73K 50 at 474.68
18.5%
Planned (10b5-1)
17 Feb 2026
Crystal Sumner See Remarks
Sold on a plan
$20.21K 5,056 at 4.00
1.6%
Planned (10b5-1)
17 Feb 2026
Sold on a plan
$19.96K 750 at 26.61
0.5%
Planned (10b5-1)
17 Feb 2026
Staffan Olsson EVP, Operations
Sold on a plan
$14.86K 119 at 124.89
5.3%
Planned (10b5-1)
17 Feb 2026
Marla J Blow Director
Sold on a plan 2×
$13.41K 300 at 44.68
3.3%
Planned (10b5-1)
17 Feb 2026
Laurence Denny Chief Legal Officer
Sold on a plan
$12.73K 5,000 at 2.55
1.3%
Planned (10b5-1)
17 Feb 2026
David Malcom Rodman Chief Medical Officer
Sold on a plan
$11.51K 417 at 27.59
0.9%
Planned (10b5-1)
17 Feb 2026
Martha Cummings Director
Sold on a plan
$11.41K 2,853 at 4.00
6.8%
Planned (10b5-1)
17 Feb 2026
Alina Kerdman SVP, Controller & CAO
Sold on a plan
$10.68K 160 at 66.75
20.3%
Planned (10b5-1)
17 Feb 2026
Ali Sadri Chief Technology Officer
Sold on a plan
$5.28K 1,000 at 5.28
0.8%
Planned (10b5-1)
17 Feb 2026
Michael Lee Milligan See Remarks
Sold on a plan
$5.12K 1,436 at 3.57
6.4%
Planned (10b5-1)
17 Feb 2026
William O'Dowd IV Chief Executive Officer
Bought on a plan
$4.85K 3,300 at 1.47
0.8%
Bought on a plan
15 Feb 2026
Richard D Francis President and CEO
Sold on a plan 2×
$15.32M 447,778 at 34.22
62.2%
Sold half or more
15 Feb 2026
Javier Olivan Chief Operating Officer
Sold on a plan
$1.57M 2,461 at 639.77
16.9%
Planned (10b5-1)
15 Feb 2026
Eric D. Shaff Director
Sold on a plan
$2.19K 259 at 8.47
2.2%
Planned (10b5-1)
15 Feb 2026
Matthew R Henn See Remarks
Sold on a plan
$753.83 89 at 8.47
1.1%
Planned (10b5-1)
15 Feb 2026
Thomas DesRosier See Remarks
Sold on a plan
$660.66 78 at 8.47
1.0%
Planned (10b5-1)
15 Feb 2026
Teresa L. Young See Remarks
Sold on a plan
$635.25 75 at 8.47
0.9%
Planned (10b5-1)
13 Feb 2026
Christopher J Kempczinski Chairman and CEO
Sold on a plan
$8.76M 26,276 at 333.54
53.4%
Sold half or more
13 Feb 2026
Vicente Reynal See Remarks
Sold on a plan
$5.61M 55,870 at 100.39
19.6%
Planned (10b5-1)
13 Feb 2026
Catherine T. Doherty EVP, Regional Businesses
Sold on a plan 5×
$5.39M 26,165 at 206.15
27.8%
Planned (10b5-1)
13 Feb 2026
Eric Venker President & Immunovant CEO
Sold on a plan
$5.30M 200,000 at 26.49
10.8%
Planned (10b5-1)
13 Feb 2026
Shadrak W Kroeger Pres., Industrial Solutions
Sold on a plan 11×
$3.73M 15,965 at 233.75
38.1%
Planned (10b5-1)
13 Feb 2026
Artur Bergman Chief Technology Officer · indirect
Sold on a plan 2×
$3.70M 200,847 at 18.42
8.0%
Planned (10b5-1)
13 Feb 2026
Sold on a plan 4×
$3.55M 10,000 at 355.18
1.0%
Planned (10b5-1)
13 Feb 2026
Ishbia Mat President and CEO · indirect
Sold on a plan
$3.13M 632,874 at 4.94
35.3%
Planned (10b5-1)
13 Feb 2026
Jill L. Robinson EVP, CFO & Treasurer
Sold on a plan
$2.52M 60,000 at 42.00
43.0%
Planned (10b5-1)
13 Feb 2026
Steve Ladd Huffman CEO & President · indirect
Sold on a plan 6×
$2.50M 18,000 at 138.81
3.9%
Planned (10b5-1)
13 Feb 2026
Yoav Landman Chief Technology Officer
Sold on a plan
$1.68M 30,000 at 55.86
0.5%
Planned (10b5-1)
13 Feb 2026
Charles Robbins Chair and CEO
Sold on a plan 4×
$1.49M 19,545 at 76.00
2.8%
Planned (10b5-1)
13 Feb 2026
Bought on a plan 3×
$1.40M 20,000 at 69.88
0.0%
Bought on a plan
13 Feb 2026
Eric Swayze EVP Research
Sold on a plan 2×
$1.28M 15,642 at 81.76
32.8%
Planned (10b5-1)
13 Feb 2026
G Frederick Bohley Allison COO,Pres.&BU Leader AT
Sold on a plan 3×
$1.20M 10,348 at 116.40
9.5%
Planned (10b5-1)
13 Feb 2026
Joseph D Mansueto Executive Chairman
Sold on a plan 6×
$1.13M 7,250 at 156.21
0.1%
Planned (10b5-1)
13 Feb 2026
Shardul Shah Director · indirect
Sold on a plan 7×
$998.89K 7,916 at 126.19
2.3%
Planned (10b5-1)
13 Feb 2026
Jeetendra I Patel President and CPO
Sold on a plan 4×
$854.85K 11,248 at 76.00
4.1%
Planned (10b5-1)
13 Feb 2026
Toby J. Williams President and CEO
Sold on a plan 2×
$837.19K 8,000 at 104.65
3.6%
Planned (10b5-1)
13 Feb 2026
Richard A Hayne CEO & Chairman of the Board
Sold on a plan
$752.12K 10,667 at 70.51
0.1%
Planned (10b5-1)
13 Feb 2026
Ourania Tatsis EVP, Chief Reg. & Quality Off.
Sold on a plan
$749.99K 1,500 at 499.99
3.1%
Planned (10b5-1)
Showing 17,051–17,100 of 23,187. ← Newer Page 342 of 464 Older →